CAMP4 Therapeutics Corporation Stock Price: Quote, Forecast, Splits & News (CAMP)

CAMP

CAMP4 Therapeutics Corporation

Financial information provided by Financial Modeling Prep. Options data provided by Unusual Whales. Live transcripts provided by Quartr. Reported revenue and EPS data from Earnings powered by FinChat.io. All data is provided for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice.

Symbol: CAMP
Market Cap: $33M
IPO Date: Oct 11, 2024
CEO: Joshua Mandel-Brehm
Fulltime Employees: 55
Sector: Healthcare
Industry: Biotechnology
Country: US
Exchange: NASDAQ

Peers

Watchlist

	2022	2023	2024
Market Cap	$378	$387	$102
- Cash	79	42	64
+ Debt	206	240	9
Enterprise Value	504	585	46
Revenue	296	295	0.7
% Growth	-	-0.3%	-99.8%
Gross Profit	122	109	0.7
% Margin	41.2%	37.0%	100.0%
EBITDA	7	0.3	-51
% Margin	2.5%	0.1%	-7,882.2%
Net Income	-31	-32	-52
% Margin	-10.5%	-11.0%	-7,943.4%
EPS Diluted	-0.88	-0.90	-2.66
% Growth	-	2.3%	195.6%
Operating Cash Flow	-4	-39	-46
Capital Expenditures	-13	-4	-0.4
Free Cash Flow	-18	-43	-46